The venerable Merck (NYSE:MRK) has turned into a hot mega-cap stock again, at least hot for a non-Internet stock, on the back of its immuno-oncology drug Keytruda. Here's a look at MRK's movement - up almost 70%, plus dividends, in five years:
Without further ado, here are 3 stocks that I found in the past two weeks or so and that I believe could lead to more interesting research. These might not result in an investment opportunity but I feel that if one looks at stocks properly in-depth he/she can always learn something new. Some of t
President Trump’s visit to Saudi Arabia has heralded billions of dollars of deal announcements, including from those with White House ties.
Private equity giant Blackstone (BX) on Saturday announced that Saudi Arabia would invest $20 billion in a new $40 billion infrastructure fund for projects mainly in the United States. On Sunday, Boeing (BA) said it had signed several defense....More>>>
Investment company Kirr Marbach & Co Llc buys Xperi, Vistra Energy, Atkore International Group, Varex Imaging, Modine Manufacturing Co, Daseke, SandRidge Energy, SandRidge Energy, Sportsman’s Warehouse Holdings, Pendrell, sells NCR, BWX Technologies, Babcock & Wilcox Enterprises, ICU Medical, Hemisphere Media Group during the 3-months ended 2017-03-31, according to the most recent....More>>>
Concerns about President Donald Trump’s possible impeachment over the firing of FBI director James Comey sent the Dow Jones Industrial Average tumbling more than 373 points. But while some investors fear the uncertainty of possible impeachment proceedings,....More>>>
Long one of the lowest rated of all U.S. industries, the country’s airlines have made something of a comeback over the past four years. In 2013 airlines scored just ahead of internet services providers (ISPs) and cable TV providers at the bottom of the rankings maintained by the American Customer Satisfaction Index. Airlines’ scores improved by 4.3% in 2016 and now rank ahead of five....More>>>
Related SBUX Jim Cramer Shares His Thoughts On Starbucks And Five Below 20 Biggest Mid-Day Losers For Friday Stock Indexes Slip; Retail Weak, But Not Credit Cards (Investor’s Business Daily) ....More>>>
The release of Ryzen, Advanced Micro Devices’ (NYSE:AMD) next generation computer processor, is fast approaching. At the end of this week, on March 2, Ryzen 7 processors will sell for between $329 to $499. The product pricing vastly changes the game for AMD’s competitive positioning against Intel (NASDAQ:INTC). At the very least, AMD will start making a profit from Ryzen sales. In the....More>>>
Both NVIDIA (NASDAQ:NVDA) and AstraZeneca (NYSE:AZN) have gained over 10% in price in the past week. NVIDIA was up due to a positive earnings beat with growth in artificial intellegence. AstraZeneca saw progress on the drug Imfinzi which is set to battle lung cancer, among other potential growth in drug pipeline research. Investors should be excited as both companies continue to execute....More>>>
Today’s seniors face a lot of challenges. While we’re living long past retirement, our money doesn’t always stretch as far as it should. Health issues further complicate matters. Chronic or catastrophic health conditions affect 92% of people over 60.
The recession was a huge bump in the road for baby boomers approaching retirement. When the economy went south, millions of....More>>>
In the past week, Sears Holdings (NASDAQ:SHLD) CEO Eddie Lampert has tried to calm investor fears that his company is teetering on the brink of bankruptcy. However, his comments have only served to fan the flames.
While Lampert has pointed to particular accomplishments at Sears Holdings, he has never really acknowledged just how bad the company’s problems are. As a result, his remarks....More>>>
Last week, shares of Axovant (NYSE:AXON) rose almost 50% on the news that Dr. David Hung, former President and CEO of Medivation, was appointed as Axovant’s new CEO. Dr. Hung rose to prominence not only for founding Medivation, but also for overseeing the company through to its $14 billion acquisition by Pfizer last year. This move likely has investors thinking Axovant may be about to meet....More>>>
Most people who call themselves "investors" really aren't. The average "investor" is really a trader. He buys a stock with the hope that at some point in the future, he'll find someone who'll buy it for more than he paid. He's trying to time the market. "Buy low and sell high," right? More often, however, people can't stand the uncertainty.....More>>>
Market crashes are no fun, but they can be made more tolerable by owning shares of high-quality, dividend-paying stocks. No stock is truly crash-proof, but some hold up much better than others. We asked three of our contributors to each pick a dividend stock that they think wouldn’t get derailed by a market crash. Their choices: McDonald’s (NYSE:MCD), Johnson & Johnson (NYSE:JNJ),....More>>>
New York, NY, based Investment company Sanders Capital, LLC buys Alphabet Inc, PepsiCo Inc, Cabot Oil & Gas Corp, SPDR S&P 500, sells Citigroup Inc, Bank of America Corporation, JPMorgan Chase, Goldman Sachs Group Inc, MetLife Inc during the 3-months ended 2017-03-31, according to the most recent filings of the investment company, Sanders Capital, LLC. As of 2017-03-31, Sanders Capital,....More>>>
Starting with a simple tweet on September 21st, 2015, Hillary Clinton has been pummeling Biotech stocks since her Presidential Campaign first began. In fact, Clinton has caused dramatic drops in the iShares Nasdaq Biotechnology ETF (IBB) at least three times in the past 14 months. The thought of Clinton winning the presidency, and the corresponding assault on the Biotech sector,....More>>>
As General Electric (NYSE:GE) stock price continues to decline amid some dubious execution of strategy and acquisitions, there seems to be nothing the company can do to assuage the concerns of investors. From acquiring Alstom to Baker Hughes (NYSE:BHI), investors and analysts have been calling for CEO Jeff Immelt’s position for quite some time now. However, the company is considering acquisitions....More>>>
The venerable Merck (NYSE:MRK) has turned into a hot mega-cap stock again, at least hot for a non-Internet stock, on the back of its immuno-oncology drug Keytruda. Here’s a look at MRK’s movement – up almost 70%, plus dividends, in five years:
MRK data by YCharts
This article explains my indifference to going long MRK shares. Given....More>>>
Without further ado, here are 3 stocks that I found in the past two weeks or so and that I believe could lead to more interesting research. These might not result in an investment opportunity but I feel that if one looks at stocks properly in-depth he/she can always learn something new. Some of them are also dark and just caught my interest because of material information that I saw online.
Bank of America’s (NYSE:BAC) shares tumbled 6 percent yesterday on concerns that the Trump rally is fading. Stocks have had a great run since the election of Donald J. Trump as U.S. president, but the administration is tangled up in all kinds of scandals, which is negatively affecting confidence in stocks. Since valuations are still pretty high, investors need to prepare themselves....More>>>
Shares of CUI Global (CUI) got slammed right after the company delivered disappointing news on Tuesday, when it announced its fourth quarter results. The stock slumped 16%, to $5.03 a share, at the market’s close that day.
Management expressed concern over the slower than expected adoption rate of the Gas PT device, an innovation for the....More>>>
Both NVIDIA (NASDAQ:NVDA) and AstraZeneca (NYSE:AZN) have gained over 10% in price in the past week. NVIDIA was up due to a positive earnings beat with growth in artificial intellegence. AstraZeneca saw progress on the drug Imfinzi which is set to battle lung cancer, among other potential gr